, TABLE OF CONTENTS
1. Prescriptive Authority
2. Rational Drug Selection and Prescription Writing
3. Promoting Positive Outcomes of Drug Therapy
4. Pharmacokinetics, Pharmacodynamics, and Drug Interactions
5. Adverse Drug Reactions and Medication Errors
6. Individual Variation in Drug Responses
7. Genetic and Genomic Considerations in Pharmacotherapeutics
8. Drug Therapy During Pregnancy and Breast-Feeding
9. Drug Therapy in Pediatric Patients
10.Drug Therapy in Geriatric Patients
11.Basic Principles of Neuropharmacology
12.Physiology of the Peripheral Nervous System
13.Muscarinic Agonists
14.Muscarinic Antagonists
15.Adrenergic Agonists
16.Adrenergic Antagonists
17.Indirect-Acting Antiadrenergic Agents
18.Introduction to Central Nervous System Pharmacology
19.Drugs for Parkinson Disease
20.Drugs for Alzheimer Disease
21.Drugs for Seizure Disorders
22.Drugs for Muscle Spasm and Spasticity
23.Local Anesthetics
24.Opioid Analgesics, Opioid Antagonists, and Nonopioid Centrally Acting
Analgesics
25.Drugs for Headache
26.Antipsychotic Agents and Their Use in Schizophrenia
27.Antidepressants
28.Drugs for Bipolar Disorder
29.Sedative-Hypnotic Drugs
30.Management of Anxiety Disorders
31.Central Nervous System Stimulants and Attention-Deficit/Hyperactivity Disorder
32.Substance Use Disorders I: Basic Considerations
33.Substance Use Disorders II: Alcohol
34.Substance Use Disorders III: Nicotine and Smoking
35.Substance Use Disorders IV: Major Drugs of Abuse Other Than Alcohol and
Nicotine
1. Prescriptive Authority
2. Rational Drug Selection and Prescription Writing
3. Promoting Positive Outcomes of Drug Therapy
4. Pharmacokinetics, Pharmacodynamics, and Drug Interactions
5. Adverse Drug Reactions and Medication Errors
6. Individual Variation in Drug Responses
7. Genetic and Genomic Considerations in Pharmacotherapeutics
8. Drug Therapy During Pregnancy and Breast-Feeding
9. Drug Therapy in Pediatric Patients
10.Drug Therapy in Geriatric Patients
11.Basic Principles of Neuropharmacology
12.Physiology of the Peripheral Nervous System
13.Muscarinic Agonists
14.Muscarinic Antagonists
15.Adrenergic Agonists
16.Adrenergic Antagonists
17.Indirect-Acting Antiadrenergic Agents
18.Introduction to Central Nervous System Pharmacology
19.Drugs for Parkinson Disease
20.Drugs for Alzheimer Disease
21.Drugs for Seizure Disorders
22.Drugs for Muscle Spasm and Spasticity
23.Local Anesthetics
24.Opioid Analgesics, Opioid Antagonists, and Nonopioid Centrally Acting
Analgesics
25.Drugs for Headache
26.Antipsychotic Agents and Their Use in Schizophrenia
27.Antidepressants
28.Drugs for Bipolar Disorder
29.Sedative-Hypnotic Drugs
30.Management of Anxiety Disorders
31.Central Nervous System Stimulants and Attention-Deficit/Hyperactivity Disorder
32.Substance Use Disorders I: Basic Considerations
33.Substance Use Disorders II: Alcohol
34.Substance Use Disorders III: Nicotine and Smoking
35.Substance Use Disorders IV: Major Drugs of Abuse Other Than Alcohol and
Nicotine
